---
title: "Guardforce AI to Present Live, Answer Questions, at Skyline Signature Series™ on July 22, 2026, at 11:00 AM ET"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292491038.md"
description: "Investors, advisors, and analysts are encouraged to participate in the upcoming event, targeting both individual and institutional attendees."
datetime: "2026-07-13T12:32:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292491038.md)
  - [en](https://longbridge.com/en/news/292491038.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292491038.md)
generator: "portal-rs"
---

# Guardforce AI to Present Live, Answer Questions, at Skyline Signature Series™ on July 22, 2026, at 11:00 AM ET

Investors, advisors, and analysts are encouraged to participate in the upcoming event, targeting both individual and institutional attendees.

### Related Stocks

- [GFAI.US](https://longbridge.com/en/quote/GFAI.US.md)
- [GFAIW.US](https://longbridge.com/en/quote/GFAIW.US.md)

## Related News & Research

- [Skyline Bankshares declares $0.32 per share semi-annual cash dividend](https://longbridge.com/en/news/296615055.md)
- [Elfa Medicamentos says Gravataí Participações buys 99.56% stake for R$ 620.49](https://longbridge.com/en/news/296788170.md)
- [HMOBI board signs off on Q2 2026 financial statements, audit review shows no qualifications](https://longbridge.com/en/news/296656112.md)
- [ES Group to present January–June interim report in webcast and conference call](https://longbridge.com/en/news/296326732.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**